Bonk stock (US48206C1071): Q1 2026 earnings show deepening loss

Bonk Inc. (NASDAQ: BNKK), formerly Jupiter Wellness and Safety Shot, reported Q1 2026 results with a deepened loss, $786K beverage revenue, and $728K cash on May 13, 2026. Shares closed at $2.20.

Bonk Inc., trading as NASDAQ: BNKK, released its Q1 2026 earnings on May 13, 2026, revealing a deepened quarterly loss amid its pivot to wellness beverages and crypto-related initiatives. Beverage sales revenue reached $786,331 for the quarter, while total assets stood at $38,387,759 and cash balance at $728,907, according to the Stock Titan report as of May 13, 2026. The stock closed at $2.20, down 2.22%, with extended trading at $2.64 (+19.77%), per MarketBeat as of May 13, 2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Bonk Inc.
• Sector/industry: Wellness and functional beverages
• Headquarters/country: United States
• Core markets: North America
• Key revenue drivers: Beverage sales, OTC products
• Home exchange/listing venue: Nasdaq (BNKK)
• Trading currency: USD

Bonk: core business model

Bonk Inc. operates as a wellness and functional beverage company, focusing on research, development, and sales of over-the-counter products and related intellectual property. Formerly known as Jupiter Wellness, Inc., it rebranded to Safety Shot, Inc. in September 2023 and then to Bonk, Inc. on October 10, 2025, following a Delaware filing on October 8, 2025, as detailed in its Q1 2026 10-Q filing reported by Stock Titan as of May 13, 2026. The company has shifted emphasis to functional beverages targeting health-conscious consumers.

This evolution includes acquisitions, such as certain assets in August 2023, positioning Bonk in the competitive wellness sector. Its portfolio emphasizes innovative beverages, with Q1 2026 revenue from this segment at $786,331, underscoring early commercialization efforts for US retail investors tracking small-cap growth names on Nasdaq.

Main revenue and product drivers for Bonk

Beverage sales represent a primary revenue driver, generating $786,331 in Q1 2026 (period ended March 31, 2026, published May 13, 2026). The company's total assets of $38,387,759 reflect investments in IP and inventory, while cash reserves of $728,907 support ongoing R&D and operations, per the SEC filing via Stock Titan.

Historical context shows a transition from wellness skincare under Jupiter Wellness to functional drinks under Safety Shot and now Bonk, with crypto-themed branding potentially appealing to niche markets. For US investors, exposure comes via Nasdaq listing, offering liquidity in the health beverage space amid rising demand for functional products.

Industry trends and competitive position

The functional beverage market continues expanding, driven by consumer demand for health-focused drinks, with US sales projected to grow steadily. Bonk positions itself with innovative formulations, though its small scale differentiates it from giants like Monster Beverage or Celsius Holdings.

Recent Q1 results highlight revenue traction but profitability challenges, common for early-stage players. Nasdaq listing provides visibility for US retail investors seeking high-growth, volatile wellness stocks.

Why Bonk matters for US investors

Listed on Nasdaq as BNKK, Bonk offers US investors direct access to a micro-cap wellness play with crypto-inspired branding, potentially tying into digital asset trends. Its $2.20 closing price on May 13, 2026, reflects volatility attractive to speculative portfolios.

With total assets over $38M and Nasdaq compliance, it serves as a pure-play on functional beverages amid US health trends, though deepening losses warrant scrutiny.

Conclusion

Bonk Inc.'s Q1 2026 earnings highlight revenue growth in beverages to $786K alongside a deepened loss and solid asset base, signaling ongoing transition challenges. The Nasdaq-listed stock's post-earnings extended gain to $2.64 underscores volatility. US investors may track future quarters for profitability progress and market expansion.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.